Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
Measurement of acetylxylan esterase in Streptomyces
1988
Johnson, K.G.; Fontana, J.D.; MacKenzie, C.R.
Methods Enzymol.
160
551-560
-
Purification and some properties of an esterase from yeast
1986
Toshimitsu, N.; Hamada, H.; Kojima, M.
J. Ferment. Technol.
64
459-462
Acylhydrolases from parsley (Petroselinum hortense). Relative distribution and properties of four esterases hydrolyzing malonic acid hemiesters of flavonoid glucosides
1983
Matern, U.
Arch. Biochem. Biophys.
224
261-271
-
Esterase activity in the hepatopancreas of Macrobrachium lamerrei (Crustacea: Decapoda)
1980
Murthy, R.C.; Saxena, P.
Experientia
36
323-325
Further evidence for the concept of bovine plasma arylesterase as a lipoprotein
1975
Don, M.M.; Masters, C.J.; Winzor, D.J.
Biochem. J.
151
625-630
Characterization of the esterases of feline serum
1974
Ecobichon, D.J.
Can. J. Biochem.
52
1073-1078
Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase
1973
Kitchen, B.J.; Masters, C.J.; Winzor, D.J.
Biochem. J.
135
93-99
Membrane marker enzymes. Characterization of an arylesterase of guinea pig cerebral cortex utilizing p-nitrophenyl acetate as substrate
1972
Bosmann, H.B.
Biochim. Biophys. Acta
276
180-191
Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera
1995
Reiner, E.; Simeon-Rudolf, V.; Skrinjaric-Spoljar, M.
Toxicol. Lett.
82/83
447-452
Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
1991
Gan, K.N.; Smolen, A.; Eckerson, H.W.; La Du, B.N.
Drug Metab. Dispos.
19
100-106
Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase
1991
Smolen, A.; Eckerson, H.W.; Gan, K.N.; Hailat, N.; La Du, B.N.
Drug Metab. Dispos.
19
107-112
A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate
1992
Haagen, L.; Brock, A.
Eur. J. Clin. Chem. Clin. Biochem.
30
391-395
Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon
1998
Pond, A.L.; Chambers, H.W.; Coyne, C.P.; Chamers, J.E.
J. Pharmacol. Exp. Ther.
286
1404-1411
Inhibition of arylesterase by aliphatic alcohols
1998
Debord, J.; Dantoine, T.; Bollinger, J.C.; Abraham, M.H.; Verneuil, B.; Merle, L.
Chem. Biol. Interact.
113
105-115
Characterization of the isoenzymes of pig-liver esterase. 2. Kinetic studies
1979
Junge, W.; Heymann, E.
Eur. J. Biochem.
95
519-525
Purification and enzymatic properties of rat serum carboxylesterase
1978
Hashinotsume, M.; Higashino, K.; Hada, T.; Yamamura, Y.
J. Biochem.
84
1325-1333
Characterization of intracellular esterase A from Bacillus subtilis
1976
Riefler III, J.F.; Higerd, T.B.
Biochim. Biophys. Acta
429
191-197
-
Carboxylesterase from pig and ox liver
1975
Dudman, N.P.B.; Zerner, B.
Methods Enzymol.
35B
190-208
Carboxylesterases (EC 3.1.1). A comparison of some kinetic properties of horse, sheep, chicken, pig, and ox liver carboxylesterases
1975
Stoops, J.K.; Hamilton, S.E.; Zerner, B.
Can. J. Biochem.
53
565-573
Purification and characterization of a carboxylesterase from the intestine of the nematode Caenorhabditis elegans
1987
McGhee, J.D.
Biochemistry
26
4101-4107
Cloning of Pseudomonas fluorescens carboxylesterase gene and characterization of its product expressed in Escherichia coli
1994
Kim, Y.S.; Lee, H.B.; Choi, K.D.; Park, S.; Yoo, O.J.
Biosci. Biotechnol. Biochem.
58
111-116
4- Hydroxyacetophenone monooxygenase from Pseudomonas fluorescens ACB: a novel flavoprotein catalyzing Baeyer-Villiger oxidation of aromatic compounds
2001
Kamerbeek, N.M.; Moonen, M.J.; van der Ven, J.G.; van Berkel, W.J.H.; Fraaije, M.W.; Janssen, D.B.
Eur. J. Biochem.
268
2547-2557
Aspirin hydrolyzing esterases from rat liver cytosol
1990
Kim, D.H.; Yang, Y.S.; Jakoby, W.B.
Biochem. Pharmacol.
40
481-487
Studies on human serum paraoxonase/arylesterase
1993
La Du, B.N.; Adkins, S.; Kuo, C.L.; Lipsig, D.
Chem. Biol. Interact.
87
25-34
Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase
1999
Rodrigo, L.; Gil, F.; Hernandez, A.F.; Pla, A.
Chem. Biol. Interact.
119-120
263-275
Comparison of purified human and rabbit serum paraoxonases
1995
Kuo, C.L.; La Du, B.N.
Drug Metab. Dispos.
23
935-944
Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals
2001
La Du, B.N.; Billecke, S.; Hsu, C.; Haley, R.W.; Broomfield, C.A.
Drug Metab. Dispos.
29
566-569
Three-dimensional structure of the zinc-containing phosphotriesterase with the bound substrate analog diethyl 4-methylbenzylphosphonate
1996
Vanhooke, J.L.; Benning, M.M.; Raushel, F.M.; Holden, H.M.
Biochemistry
35
6020-6025
Substrate specificity and enantioselectivity of 4-hydroxyacetophenone monooxygenase
2003
Kamerbeek, N.M.; Olsthoorn, A.J.J.; Fraaije, M.W.; Janssen, D.B.
Appl. Environ. Microbiol.
69
419-426
Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties
2003
Rodrigo, L.; Gil, F.; Hernandez, A.F.; Lopez, O.; Pla, A.
Biochem. J.
376
261-268
Continuous monitoring of arylesterase in human serum
2001
Lorentz, K.; Wirtz, W.; Weiss, T.
Clin. Chim. Acta
308
69-78
Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters
2000
Billecke, S.; Draganov, D.; Counsell, R.; Stetson, P.; Watson, C.; Hsu, C.; La Du, B.N.
Drug Metab. Dispos.
28
1335-1342
Characterization of an arylesterase from Lactobacillus helveticus CNRZ32
2000
Fenster, K.M.; Parkin, K.L.; Steele, J.L.
J. Appl. Microbiol.
88
572-583
Conversion of 4-hydroxyacetophenone into 4-phenyl acetate by a flavin adenine dinucleotide-containing Baeyer-Villiger-type monooxygenase
2000
Tanner, A.; Hopper, D.J.
J. Bacteriol.
182
6565-6569
Observation of an arsenic adduct in an acetyl esterase crystal structure
2003
Zhu, X.; Larsen, N.A.; Basran, A.; Bruce, N.C.; Wilson, I.A.
J. Biol. Chem.
278
2008-2014
Intracellular esterase from Lactobacillus casei LILA: nucleotide sequencing, purification, and characterization
2003
Fenster, K.M.; Parkin, K.L.; Steele, J.L.
J. Dairy Sci.
86
1118-1129
Nucleotide sequencing, purification, and biochemical properties of an arylesterase from Lactobacillus casei LILA
2003
Fenster, K.M.; Parkin, K.L.; Steele, J.L.
J. Dairy Sci.
86
2547-2557
Baculovirus-mediated expression and purification of human serum paraoxonase 1A
2001
Brushia, R.J.; Forte, T.M.; Oda, M.N.; La Du, B.N.; Bielicki, J.K.
J. Lipid Res.
42
951-958
Cloning, heterologous expression, renaturation, and characterization of a cold-adapted esterase with unique primary structure from a psychrotroph Pseudomonas sp. strain B11-1
2003
Suzuki, T.; Nakayama, T.; Choo, D.W.; Hirano, Y.; Kurihara, T.; Nishino, T.; Esaki, N.
Protein Expr. Purif.
30
171-178
Cloning, high level expression of human paraoxonase-3 in Sf9 cells and pharmacological characterization of its product
2005
Lu, H.; Zhu, J.; Zang, Y.; Ze, Y.; Qin, J.
Biochem. Pharmacol.
70
1019-1025
High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I
2005
Gaidukov, L.; Tawfik, D.S.
Biochemistry
44
11843-11854
Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase
2005
Khersonsky, O.; Tawfik, D.S.
Biochemistry
44
6371-6382
Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model
2004
Yeung, D.T.; Josse, D.; Nicholson, J.D.; Khanal, A.; McAndrew, C.W.; Bahnson, B.J.; Lenz, D.E.; Cerasoli, D.M.
Biochim. Biophys. Acta
1702
67-77
Distribution spectrum of paraoxonase activity in HDL fractions
2004
Bergmeier, C.; Siekmeier, R.; Gross, W.
Clin. Chem.
50
2309-2315
Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates
2005
Yeung, D.T.; Lenz, D.E.; Cerasoli, D.M.
FEBS J.
272
2225-2230
Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver
2004
Kondo, Y.; Ishigami, A.; Kubo, S.; Handa, S.; Gomi, K.; Hirokawa, K.; Kajiyama, N.; Chiba, T.; Shimokado, K.; Maruyama, N.
FEBS Lett.
570
57-62
Effect of 3,4-dihydroxyphenylalanine on Cu2+-induced inactivation of HDL-associated paraoxonase1 and oxidation of HDL; inactivation of paraoxonase1 activity independent of HDL lipid oxidation
2004
Nguyen, S.D.; Sok, D.E.
Free Radic. Res.
38
969-976
The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases
2006
Khersonsky, O.; Tawfik, D.S.
J. Biol. Chem.
281
7649-7656
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
2005
Draganov, D.I.; Teiber, J.F.; Speelman, A.; Osawa, Y.; Sunahara, R.; La Du, B.N.
J. Lipid Res.
46
1239-1247
Bovine paraoxonase 1 activities in serum and distribution in lipoproteins
2005
Miyamoto, T.; Takahashi, Y.; Oohashi, T.; Sato, K.; Oikawa, S.
J. Vet. Med. Sci.
67
243-248
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization
2004
Aharoni, A.; Gaidukov, L.; Yagur, S.; Toker, L.; Silman, I.; Tawfik, D.S.
Proc. Natl. Acad. Sci. USA
101
482-487
Cloning, purification, and refolding of human paraoxonase-3 expressed in Escherichia coli and its characterization
2006
Lu, H.; Zhu, J.; Zang, Y.; Ze, Y.; Qin, J.
Protein Expr. Purif.
46
92-99
Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks
2006
Sumegova, K.; Blazicek, P.; Waczulikova, I.; Zitnanova, I.; Durackova, Z.
Acta Biochim. Pol.
53
783-787
Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus
2006
Juretic, D.; Motejlkova, A.; Kunovi?, B.; Reki?, B.; Flegar-Mestri?, Z.; Vuji?, L.; Mesi?, R.; Lukac-Bajalo, J.; Simeon-Rudolf, V.
Acta Pharm.
56
59-68
Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position
2006
Nguyen, S.D.; Sok, D.E.
Biochim. Biophys. Acta
1758
499-508
Stability of highly purified human paraoxonase (PON1): Association with human phosphate binding protein (HPBP) is essential for preserving its active conformation(s)
2007
Rochu, D.; Renault, F.; Clery-Barraud, C.; Chabriere, E.; Masson, P.
Biochim. Biophys. Acta
1774
874-883
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke
2008
Can Demirdoegen, B.; Tuerkanoglu, A.; Bek, S.; Sanisoglu, Y.; Demirkaya, S.; Vural, O.; Arinc, E.; Adali, O.
Clin. Biochem.
41
1-9
The effect of diet on paraoxonase 1/arylesterase activities in patients with disorders of galactose metabolism
2007
Schulpis, K.H.; Karikas, G.A.; Bartzeliotou, A.; Papakonstantinou, E.D.; Kalogerakou, M.; Tsakiris, S.
Clin. Endocrinol. (Oxf.)
67
687-692
Paraoxonase and arylesterase levels in rheumatoid arthritis
2007
Isik, A.; Koca, S.S.; Ustundag, B.; Celik, H.; Yildirim, A.
Clin. Rheumatol.
26
342-348
EstA from Arthrobacter nitroguajacolicus Rue61a, a thermo- and solvent-tolerant carboxylesterase related to class C beta-lactamases
2007
Schuette, M.; Fetzner, S.
Curr. Microbiol.
54
230-236
Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet
2007
Schulpis, K.H.; Bartzeliotou, A.; Tsakiris, S.; Gounaris, A.; Papassotiriou, I.
Eur. J. Clin. Nutr.
61
803-808
Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography
2006
Renault, F.; Chabriere, E.; Andrieu, J.; Dublet, B.; Masson, P.; Rochu, D.
J. Chromatogr. B
836
15-21
Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound
2006
Park, C.H.; Nguyen, S.D.; Kim, M.R.; Jeong, T.S.; Sok, D.E.
Lipids
41
371-380
Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats
2008
Farid, A.S.; Nakahara, K.; Murakami, N.; Hayashi, T.; Horii, Y.
Am. J. Trop. Med. Hyg.
78
770-776
Paraoxonase activity against nerve gases measured by capillary electrophoresis and characterization of human serum paraoxonase (PON1) polymorphism in the coding region (Q192R)
2009
Kanamori-Kataoka, M.; Seto, Y.
Anal. Biochem.
385
94-100
Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies
2009
Efrat, M.; Rosenblat, M.; Mahmood, S.; Vaya, J.; Aviram, M.
Atherosclerosis
202
461-469
Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity
2008
Tavori, H.; Khatib, S.; Aviram, M.; Vaya, J.
Bioorg. Med. Chem.
16
7504-7509
Growth hormone improves lipoprotein concentration and arylesterase activity in mice with an atherogenic lipid profile induced by lactalbumin
2009
Lopez-Oliva, E.; Nus, M.; Agis-Torres, A.; Villaro, W.; Sanchez-Montero, J.M.; Munoz-Martinez, E.; Sanchez-Muniz, F.J.
Br. J. Nutr.
101
518-526
Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation
2008
Krzystek-Korpacka, M.; Boehm, D.; Matusiewicz, M.; Diakowska, D.; Grabowski, K.; Gamian, A.
Clin. Biochem.
41
804-811
Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs
2009
Kasprzak, M.; Iskra, M.; Majewski, W.; Wielkoszynski, T.
Clin. Biochem.
42
50-56
High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain
2008
Garces, C.; Lopez-Simon, L.; Rubio, R.; Benavente, M.; Cano, B.; Ortega, H.; de Oya, M.
Clin. Chem. Lab. Med.
46
809-813
High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus
2009
Dullaart, R.P.; de Vries, R.; Sluiter, W.J.; Voorbij, H.A.
Clin. Endocrinol. (Oxf.)
70
221-226
-
Determination of rat and mice arylesterase activity using serum mimetics
2008
Nus, M.; Sanchez-Muniz, F.J.; Gago, J.V.; Lopez-Oliva, E.; Sanchez-Montero, J.M.
Enzyme Microb. Technol.
43
252-256
Increased glutathione levels and activity of PON1 (phenyl acetate esterase) in the liver of rats after a single dose of cyclophosphamide: a defense mechanism?
2008
Abraham, P.; Sugumar, E.
Exp. Toxicol. Pathol.
59
301-306
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer
2009
Camuzcuoglu, H.; Arioz, D.T.; Toy, H.; Kurt, S.; Celik, H.; Erel, O.
Gynecol. Oncol.
112
481-485
Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: Relation with disease severity
2009
Keskin, M.; Dolar, E.; Dirican, M.; Kiyici, M.; Yilmaz, Y.; Gurel, S.; Nak, S.G.; Erdinc, S.; Gulten, M.
Intern. Med. J.
39
243-248
Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities
2008
Rock, W.; Rosenblat, M.; Miller-Lotan, R.; Levy, A.P.; Elias, M.; Aviram, M.
J. Agric. Food Chem.
56
8704-8713
A novel thermostable arylesterase from the archaeon Sulfolobus solfataricus P1: purification, characterization, and expression
2008
Park, Y.J.; Yoon, S.J.; Lee, H.B.
J. Bacteriol.
190
8086-8095
Paraoxonase 1 activities and polymorphisms in autism spectrum disorders
2010
Pasca, S.P.; Dronca, E.; Nemes, B.; Kaucsar, T.; Endreffy, E.; Iftene, F.; Benga, I.; Cornean, R.; Dronca, M.
J. Cell. Mol. Med.
14
600-607
Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1
2008
Stoltz, D.A.; Ozer, E.A.; Taft, P.J.; Barry, M.; Liu, L.; Kiss, P.J.; Moninger, T.O.; Parsek, M.R.; Zabner, J.
J. Clin. Invest.
118
3123-3131
Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum
2009
Aksoy, H.; Aksoy, A.N.; Ozkan, A.; Polat, H.
J. Clin. Lab. Anal.
23
105-109
Cloning and characterization of thermostable esterase from Archaeoglobus fulgidus
2008
Kim, S.B.; Lee, W.; Ryu, Y.W.
J. Microbiol.
46
100-107
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS
2008
Wills, A.M.; Landers, J.E.; Zhang, H.; Richter, R.J.; Caraganis, A.J.; Cudkowicz, M.E.; Furlong, C.E.; Brown, R.H.
Neurology
70
929-934
Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning
2008
Stevens, R.C.; Suzuki, S.M.; Cole, T.B.; Park, S.S.; Richter, R.J.; Furlong, C.E.
Proc. Natl. Acad. Sci. USA
105
12780-12784
In silico analyses of substrate interactions with human serum paraoxonase 1
2009
Hu, X.; Jiang, X.; Lenz, D.E.; Cerasoli, D.M.; Wallqvist, A.
Proteins
75
486-498
Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities
2009
Karikas, G.A.; Schulpis, K.H.; Bartzeliotou, A.; Regoutas, S.; Thanopoulou, C.; Papaevangelou, V.; Giannoulia-Karantana, A.; Papassotiriou, I.; Fytou-Pallikari, A.
Scand. J. Clin. Lab. Invest.
69
31-35
Paraoxonase 1 (PON1) status and substrate hydrolysis
2009
Richter, R.J.; Jarvik, G.P.; Furlong, C.E.
Toxicol. Appl. Pharmacol.
235
1-9
Localization and characterization of the novel protein encoded by C20orf3
2008
Ilhan, A.; Gartner, W.; Nabokikh, A.; Daneva, T.; Majdic, O.; Cohen, G.; Boehmig, G.A.; Base, W.; Hoerl, W.H.; Wagner, L.
Biochem. J.
414
485-495
Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1)
2009
Nguyen, S.D.; Hung, N.D.; Cheon-Ho, P.; Ree, K.M.; Dai-Eun, S.
Biochim. Biophys. Acta
1790
155-160
Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-Exposed agricultural pesticide handlers
2009
Hofmann, J.; Keifer, M.; Furlong, C.; De Roos, A.; Farin, F.; Fenske, R.; van Belle, G.; Checkoway, H.
Environ. Health Perspect.
117
1402-1408
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
2009
Popa, C.; van Tits, L.J.; Barrera, P.; Lemmers, H.L.; van den Hoogen, F.H.; van Riel, P.L.; Radstake, T.R.; Netea, M.G.; Roest, M.; Stalenhoef, A.F.
Ann. Rheum. Dis.
68
868-872
Synthesis of cholesterol-conjugated magnetic nanoparticles for purification of human paraoxonase 1
2010
Samra, Z.Q.; Shabir, S.; Rehmat, Z.; Zaman, M.; Nazir, A.; Dar, N.; Athar, M.A.
Appl. Biochem. Biotechnol.
162
671-686
Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae
2010
Otto, T.C.; Kasten, S.A.; Kovaleva, E.; Liu, Z.; Buchman, G.; Tolosa, M.; Davis, D.; Smith, J.R.; Balcerzak, R.; Lenz, D.E.; Cerasoli, D.M.
Chem. Biol. Interact.
187
388-392
Integrative analytical approach by capillary electrophoresis and kinetics under high pressure optimized for deciphering intrinsic and extrinsic cofactors that modulate activity and stability of human paraoxonase (PON1)
2010
Renault, F.; Carus, T.; Clery-Barraud, C.; Elias, M.; Chabriere, E.; Masson, P.; Rochu, D.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
878
1346-1355
Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus
2009
Camuzcuoglu, H.; Toy, H.; Cakir, H.; Celik, H.; Erel, O.
J. Womens Health (Larchmt)
18
1435-1439
Molecular cloning and characterization of a novel SGNH arylesterase from the goat rumen contents
2011
Wang, G.; Meng, K.; Luo, H.; Wang, Y.; Huang, H.; Shi, P.; Pan, X.; Yang, P.; Yao, B.
Appl. Microbiol. Biotechnol.
91
1561-1570
-
L-arginine ameliorates arylesterase/paraoxonase activity of paraoxonase-1 in hypercholesterolemic rats
2011
Harisa, G.
Asian J. Biochem.
6
263-272
Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs
2011
Valiyaveettil, M.; Alamneh, Y.; Rezk, P.; Biggemann, L.; Perkins, M.W.; Sciuto, A.M.; Doctor, B.P.; Nambiar, M.P.
Biochem. Pharmacol.
81
800-809
Effects of Nori- and Wakame-enriched meats with or without supplementary cholesterol on arylesterase activity, lipaemia and lipoproteinaemia in growing Wistar rats
2011
Olivero-David, R.; Schultz-Moreira, A.; Vazquez-Velasco, M.; Gonzalez-Torres, L.; Bastida, S.; Benedi, J.; Isabel Sanchez-Reus, M.; Jose Gonzalez-Munoz, M.; Sanchez-Muniz, F.J.
Br. J. Nutr.
106
1476-1486
Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study
2011
Moghtaderi, A.; Hashemi, M.; Dabiri, S.; Moazeni-Roodi, A.; Hosseini, M.
Clin. Biochem.
44
288-292
Activatory effect of substrates on the cholinesterase catalysis
2010
Rozengart, E.; Basova, N.
Dokl. Biochem. Biophys.
430
7-10
Serum paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran
2011
Hashemi, M.; Kordi-Tamandani, D.M.; Sharifi, N.; Moazeni-Roodi, A.; Kaykhaei, M.A.; Narouie, B.; Torkmanzehi, A.
Eur. J. Endocrinol.
164
219-222
-
Serum paraoxonase and arylesterase activities in esophageal cancer: A controlled study
2010
Cayir, K.; Bilici, M.; Tekin, S.; Kara, F.; Turkyilmaz, A.; Yildirim, A.
Eur. J. Gen. Med.
7
398-403
Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes
2011
Bayrak, A.; Bayrak, T.; Demirpence, E.; Kilinc, K.
J. Chromatogr. B
879
49-55
Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection
2011
Duygu, F.; Tekin Koruk, S.; Aksoy, N.
J. Clin. Lab. Anal.
25
311-316
The putative lipase, AF1763, from Archaeoglobus fulgidus is a carboxylesterase with a very high pH optimum
2005
Rusnak, M.; Nieveler, J.M Schmid, R. D.; Petri, R.
Biotechnol. Lett.
27
743-748
Purification and characterization of paraoxonase 1 (PON1) from Swiss Black, Holstein, and Montofon bovines
2014
Erzengin, M.; Demir, D.; Arslan, M.; Sinan, S.
Appl. Biochem. Biotechnol.
173
1597-1606
Characterization of a feruloyl esterase from Lactobacillus plantarum
2013
Esteban-Torres, M.; Reveron, I.; Mancheno, J.M.; de Las Rivas, B.; Munoz, R.
Appl. Environ. Microbiol.
79
5130-5136
Structural characterization and function determination of a nonspecific carboxylate esterase from the amidohydrolase superfamily with a promiscuous ability to hydrolyze methylphosphonate esters
2014
Xiang, D.F.; Kumaran, D.; Swaminathan, S.; Raushel, F.M.
Biochemistry
53
3476-3485
Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1
2014
Bajaj, P.; Aggarwal, G.; Tripathy, R.K.; Pande, A.H.
Biochimie
105
202-210
Temperature dependence of binding and catalysis for human serum arylesterase/paraoxonase
2014
Debord, J.; Bollinger, J.C.; Harel, M.; Dantoine, T.
Biochimie
97
72-77
SacPox from the thermoacidophilic crenarchaeon Sulfolobus acidocaldarius is a proficient lactonase
2014
Bzdrenga, J.; Hiblot, J.; Gotthard, G.; Champion, C.; Elias, M.; Chabriere, E.
BMC Res. Notes
7
333
Molecular characterization of a novel arylesterase from the wine-associated acetic acid bacterium Gluconobacter oxidans 621H
2012
Navarro-Gonzalez, I.; Sanchez-Ferrer, A.; Garcia-Carmona, F.
J. Agric. Food Chem.
60
10789-10795
Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme
2013
Bajaj, P.; Tripathy, R.K.; Aggarwal, G.; Pande, A.H.
Protein Sci.
22
1799-1807
New chemiluminescent substrates of paraoxonase 1 with improved specificity synthesis and properties
2015
Abulimite, Z.; Mu, X.; Xiao, S.; Liu, M.; Li, Q.; Chen, G.
Appl. Biochem. Biotechnol.
176
301-316
Towards understanding the catalytic mechanism of human paraoxonase 1 experimental and in silico mutagenesis studies
2017
Tripathy, R.K.; Aggarwal, G.; Bajaj, P.; Kathuria, D.; Bharatam, P.V.; Pande, A.H.
Appl. Biochem. Biotechnol.
182
1642-1662
Effect of certain non-steroidal anti-inflammatory drugs on the paraoxonase 2 (PON2) in human monocytic cell line U937
2018
Solmaz Avcikurt, A.; Korkut, O.
Arch. Physiol. Biochem.
124
378-382
Paraoxonase and arylesterase levels in Behcets disease and their relations with the disease activity
2017
Kul, A.; Uzkeser, H.; Ozturk, N.
Biochem. Genet.
55
335-344
Characterization of cross-linked immobilized arylesterase from Gluconobacter oxydans 621H with activity toward cephalosporin C and 7-aminocephalosporanic acid
2016
Inmaculada, N.; Francisco, G.
Biotechnol. Prog.
32
36-42
Rational design of paraoxonase 1 (PON1) for the efficient hydrolysis of organophosphates
2015
Le, Q.A.; Chang, R.; Kim, Y.H.
Chem. Commun. (Camb.)
51
14536-14539
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications
2016
Zsiros, N.; Koncsos, P.; Lorincz, H.; Seres, I.; Katko, M.; Szentpeteri, A.; Varga, V.E.; Fueloep, P.; Paragh, G.; Harangi, M.
Clin. Biochem.
49
862-867
Alteration of paraoxonase, arylesterase and lactonase activities in people around fluoride endemic area of Tamil Nadu, India
2017
Arulkumar, M.; Vijayan, R.; Penislusshiyan, S.; Sathishkumar, P.; Angayarkanni, J.; Palvannan, T.
Clin. Chim. Acta
471
206-215
The effect of divalent metal chelators and cadmium on serum phosphotriesterase, lactonase and arylesterase activities of paraoxonase 1
2018
Bizon, A.; Milnerowicz, H.
Environ. Toxicol. Pharmacol.
58
77-83
Serum paraoxonase and arylesterase values as antioxidants in healthy premature infants at fasting and posprandial times
2015
Kahveci, H.; Laloglu, F.; Kilic, O.; Ciftel, M.; Yildirim, A.; Orbak, Z.; Ertekin, V.; Laloglu, E.
Eur. Rev. Med. Pharmacol. Sci.
19
1761-1765
The activities of serum paraoxonase and arylesterase and lipid profile in acute myeloid leukemia preliminary results
2015
Cebi, A.; Akgun, E.; Esen, R.; Demir, H.; Cifci, A.
Eur. Rev. Med. Pharmacol. Sci.
19
4590-4594
The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes
2016
Zargari, M.; Sharafeddin, F.; Mahrooz, A.; Alizadeh, A.; Masoumi, P.
Exp. Biol. Med.
241
1489-1496
Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans
2018
Perla-Kajan, J.; Borowczyk, K.; Glowacki, R.; Nygard, O.; Jakubowski, H.
FASEB J.
32
6019
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
2016
Castellazzi, M.; Trentini, A.; Romani, A.; Valacchi, G.; Bellini, T.; Bonaccorsi, G.; Fainardi, E.; Cavicchio, C.; Passaro, A.; Zuliani, G.; Cervellati, C.
Int. J. Biochem. Cell Biol.
81
356-363
Paraoxonase and arylesterase levels in autoimmune thyroid diseases
2016
Korkmaz, H.; Tabur, S.; Ozkaya, M.; Oguz, E.; Elboga, U.; Aksoy, N.; Akarsu, E.
Redox Rep.
21
227-231
Paraoxonase and arylesterase activities in patients with papillary thyroid cancer
2015
Korkmaz, H.; Tabur, S.; Oezkaya, M.; Aksoy, N.; Yildiz, H.; Akarsu, E.
Scand. J. Clin. Lab. Invest.
75
259-264
An indoleacetate-CoA ligase and a phenylsuccinyl-CoA transferase involved in anaerobic metabolism of auxin
2016
Schuehle, K.; Nies, J.; Heider, J.
Environ. Microbiol.
18
3120-3132